Chimera Investment (CIM)
(Delayed Data from NYSE)
$15.48 USD
-0.02 (-0.13%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $15.50 +0.02 (0.13%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Income Statements
Fiscal Year end for Chimera Investment Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 773 | 773 | 938 | 1,030 | 1,361 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 773 | 773 | 938 | 1,030 | 1,361 |
Selling & Adminstrative & Depr. & Amort Expenses | 561 | 1,146 | -42 | 1,001 | 1,335 |
Income After Depreciation & Amortization | 212 | -373 | 979 | 29 | 27 |
Non-Operating Income | -86 | -140 | -305 | 60 | 387 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 126 | -513 | 675 | 89 | 414 |
Income Taxes | 0 | 0 | 4 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 126 | -513 | 670 | 89 | 414 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 126 | -513 | 670 | 89 | 414 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 260 | -312 | 1,058 | 92 | 57 |
Depreciation & Amortization (Cash Flow) | 48 | 61 | 79 | 63 | 30 |
Income After Depreciation & Amortization | 212 | -373 | 979 | 29 | 27 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 77.53 | 77.97 | 81.82 | 75.47 | 62.80 |
Diluted EPS Before Non-Recurring Items | 1.53 | 3.24 | 5.34 | 4.38 | 6.75 |
Diluted Net EPS (GAAP) | 0.69 | -7.53 | 7.32 | 0.21 | 5.43 |
Fiscal Year end for Chimera Investment Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 186.72 | 186.57 | 191.20 | 195.59 | 196.86 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 186.72 | 186.57 | 191.20 | 195.59 | 196.86 |
SG&A, R&D, and Dept/Amort Expenses | 123.55 | 54.07 | 136.59 | 187.50 | 125.81 |
Income After SG&A, R&D, and Dept/Amort Expenses | 63.17 | 132.50 | 54.61 | 8.09 | 71.05 |
Non-Operating Income | -6.47 | -3.04 | -24.06 | -5.85 | -35.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | 56.70 | 129.46 | 30.55 | 2.25 | 36.05 |
Income Taxes | 0.03 | 0.01 | 0.00 | 0.08 | 0.03 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 56.66 | 129.45 | 30.54 | 2.17 | 36.02 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 56.66 | 129.45 | 30.54 | 2.17 | 36.02 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 82.28 | 81.71 | 80.69 | 75.57 | 77.95 |
Diluted EPS Before Non-Recurring Items | 0.37 | 0.36 | 0.39 | 0.39 | 0.36 |
Diluted Net EPS (GAAP) | 0.41 | 1.35 | 0.15 | -0.21 | 0.24 |